US 8999294
Nanoparticles for use in tumor diagnosis and therapy
granted A61KA61K41/0052A61K49/0485
Quick answer
US patent 8999294 (Nanoparticles for use in tumor diagnosis and therapy) held by The Board of Regents of the University of Texas System expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K41/0052, A61K49/0485, A61P, A61P35/00